Home » PROFECTUS BIOSCIENCES, INC. ANNOUNCES ADDITIONAL $3 MILLION PRIVATE PLACEMENT OF EQUITY SECURITIES
PROFECTUS BIOSCIENCES, INC. ANNOUNCES ADDITIONAL $3 MILLION PRIVATE PLACEMENT OF EQUITY SECURITIES
Profectus BioSciences, Inc., a biotechnology company that develops preventative and therapeutic technologies to reduce the morbidity and mortality caused by viral diseases, today announced that it has completed an additional $3 million private equity placement with the sale of securities to private investors led by Cross Atlantic Capital Partners.
Business Wire
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May